Pfizer Makes a Point at ASCO
Okay, maybe it’s a cloying move by Pfizer to protest the absurdity of government oversight. But it’s also kind of funny. The world’s largest drug...
Read More
-
About Pathophilia
This Is News? Whistleblowers Paint Themselves in Altruistic Light
Successful whistleblowers in qui tam suits against pharma weren’t in it for the money. At least that’s what they say in hindsight, according to a newly...
Read More
CMSS: All Aboard the Independence-Transparency Train
Yesterday the Council of Medical Specialty Societies, a nonprofit umbrella group of 32 medical groups, announced its guidelines for interacting with industry....
Read More
Pfizer Boards Disclosure Train
Like GSK, Lilly, and Merck, Pfizer has begun to publicly disclose its payments to US docs for their advising and speaker services, as of yesterday.* However, unlike the...
Read More
Duke Wins ACC Showdown
This week, the ACC, as an arena for impassioned conflict, didn’t stand solely for the Atlantic Coast Conference. A heated confrontation also occurred at the...
Read More
DTC Trends: Pregunte a su doctor
Pharma’s financial layout in 2009 for DTC ads remained, for all practical purposes, stable, when compared with 2008’s numbers. According to the latest...
Read More